(Q36929535)

17 August 2017

Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies (English)

1 reference

17 August 2017

1 reference

Roxana Mesias

5

0 references

Rita Cowell

Rita M Cowell

11

0 references

Deanna L. Benson

Deanna L Benson

9

0 references

Andrew B. West

Andrew B West

13

0 references

Charles L White

Charles L White

10

0 references

Dario Alessi

Dario R Alessi

7

0 references

Thomas G Beach

8

Thomas G Beach

1 reference

17 August 2017

Paul Davies

1

1 reference

17 August 2017

Kelly M Hinkle

2

1 reference

17 August 2017

Nour N Sukar

3

1 reference

17 August 2017

Bryan Sepulveda

4

1 reference

17 August 2017

Geidy Serrano

6

1 reference

17 August 2017

Sonal S Das

12

1 reference

17 August 2017

Heather L Melrose

14

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

17 August 2017

1 reference

17 August 2017

453

1 reference

17 August 2017

1

1 reference

17 August 2017

101-113

1 reference

Creative Commons Attribution 3.0 Unported

17 August 2017

start time

25 July 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

LRRK2 inhibition attenuates microglial inflammatory responses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

Genetic mouse models for understanding LRRK2 biology, pathology and pre-clinical application

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

On the road to leucine-rich repeat kinase 2 signalling: evidence from cellular and in vivo studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

Dynamic and redundant regulation of LRRK2 and LRRK1 expression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

Localization of LRRK2 to membranous and vesicular structures in mammalian brain

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

Distribution of PINK1 and LRRK2 in rat and mouse brain

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

Anatomical localization of leucine-rich repeat kinase 2 in mouse brain

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682752

NS21: re-defined and modified supplement B27 for neuronal cultures

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1042%2FBJ20121742

Microwave-stimulated recovery of myosin-V immunoreactivity from formalin-fixed, paraffin-embedded human CNS.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1042%2FBJ20121742

21 January 2018

Identifiers

DOI

10.1042/BJ20121742

1 reference

17 August 2017

1 reference

17 August 2017

1 reference